Lipocine Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2012 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Lipocine Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2012 to Q3 2024.
  • Lipocine Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 6, 2024 was 5.35M shares, a 0.6% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 5.35M +32.1K +0.6% Nov 6, 2024 10-Q 2024-11-07
Q2 2024 5.35M +32.1K +0.6% Aug 8, 2024 10-Q 2024-08-08
Q1 2024 5.32M -83.2M -94% Mar 5, 2024 10-K 2024-03-07
Q3 2023 5.32M -83.2M -94% Nov 6, 2023 10-Q 2023-11-08
Q2 2023 5.32M -83.2M -94% Aug 8, 2023 10-Q 2023-08-10
Q1 2023 88.5M +220K +0.25% Mar 7, 2023 10-K 2023-03-10
Q3 2022 88.5M +220K +0.25% Nov 7, 2022 10-Q 2022-11-09
Q2 2022 88.5M +220K +0.25% Aug 3, 2022 10-Q 2022-08-08
Q1 2022 88.3M 0 0% Mar 7, 2022 10-K 2022-03-09
Q3 2021 88.3M +22.6M +34.4% Nov 9, 2021 10-Q 2021-11-10
Q2 2021 88.3M +22.7M +34.6% Aug 4, 2021 10-Q 2021-08-05
Q1 2021 88.3M +40.4M +84.5% Mar 9, 2021 10-K 2021-03-11
Q3 2020 65.7M +40.3M +159% Nov 9, 2020 10-Q 2020-11-10
Q2 2020 65.6M +40.7M +164% Aug 4, 2020 10-Q 2020-08-06
Q1 2020 47.9M +24M +100% Mar 30, 2020 10-K 2020-03-13
Q3 2019 25.4M +3.94M +18.3% Nov 11, 2019 10-Q 2019-11-12
Q2 2019 24.8M +3.58M +16.8% Aug 5, 2019 10-Q 2019-08-07
Q1 2019 23.9M +2.61M +12.3% Mar 4, 2019 10-K 2019-03-06
Q3 2018 21.5M +267K +1.26% Nov 5, 2018 10-Q 2018-11-07
Q2 2018 21.3M +592K +2.86% Aug 6, 2018 10-Q 2018-08-07
Q1 2018 21.3M +2.67M +14.4% Mar 9, 2018 10-K 2018-03-12
Q3 2017 21.2M +2.94M +16.1% Nov 8, 2017 10-Q 2017-11-08
Q2 2017 20.7M +2.41M +13.2% Aug 4, 2017 10-Q 2017-08-07
Q1 2017 18.6M +341K +1.87% Mar 3, 2017 10-K 2017-03-06
Q3 2016 18.3M +7.44K +0.04% Nov 8, 2016 10-Q 2016-11-08
Q2 2016 18.3M +14.2K +0.08% Aug 9, 2016 10-Q 2016-08-09
Q1 2016 18.3M +5.4M +42.1% Mar 9, 2016 10-K 2016-03-10
Q3 2015 18.3M +5.47M +42.8% Nov 11, 2015 10-Q 2015-11-12
Q2 2015 18.2M +5.46M +42.7% Aug 10, 2015 10-Q 2015-08-11
Q1 2015 12.8M +76.3K +0.6% Mar 11, 2015 10-K 2015-03-11
Q3 2014 12.8M +1.73M +15.7% Nov 10, 2014 10-Q 2014-11-10
Q2 2014 12.8M +9.29M +265% Aug 13, 2014 10-Q 2014-08-13
Q1 2014 12.8M +9.27M +265% Mar 27, 2014 10-K 2014-03-31
Q3 2013 11.1M +7.56M +216% Nov 12, 2013 10-Q 2013-11-13
Q2 2013 3.5M Jul 8, 2013 10-Q 2013-07-09
Q1 2013 3.5M 0 0% Apr 24, 2013 10-Q 2013-04-24
Q3 2012 3.5M Oct 16, 2012 10-Q 2012-10-26
Q1 2012 3.5M May 8, 2012 10-Q 2012-07-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.